3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
17
Phase 3
5
Phase 2/3
2
Phase 1
2
Phase NA
1
Phase 4
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Rectal Neoplasms
1
Colorectal Neoplasms
1
Interventions
Capecitabine
13
Fluorouracil
11
Oxaliplatin
10
Bevacizumab
9
Leucovorin
6
Irinotecan
6
HMPL-013
4
Folfox protocol
4
Cetuximab
4
ferric carboxymaltose
3
regorafenib
2
gadolinium ethoxybenzyl DTPA
2
gadobenic acid
2
Triamcinolone
2
Standard of Care
2
Radiofrequency Ablation
2
Pirinitramide
2
Morphine
2
Esomeprazole
2
Analgesia, Epidural
2
zidovudine 5'-monophosphate-mannose-albumin conjugate
1
sodium phosphate
1
raltitrexed
1
polyethylene glycol 3350
1
iron isomaltoside 1000
1
galactosamine-conjugated serum albumin-conjugated-(rhodamine X)20
1
gadoteridol
1
gadoterate meglumine
1
gadodiamide
1
gadobutrol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Colorectal Neoplasms
×
XELOX
×
Clear all
NCT06115174
2023-11-02
CRC - PTX
Tanta University
Phase 4
Unknown
44 enrolled